These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 8164813)
1. A follow-up survey of clinical practices for the use of heparin, warfarin, and aspirin. Alberts MJ; Dawson DV; Massey EW Neurology; 1994 Apr; 44(4):618-21. PubMed ID: 8164813 [TBL] [Abstract][Full Text] [Related]
2. Antiplatelets and Anticoagulants in Ischemic Stroke,Transient Ischaemic Attack: A Practice Survey Among Singapore Neurologists. Venketasubramanian N Acta Neurol Taiwan; 2022 Dec; 31(4)():154-160. PubMed ID: 35470408 [TBL] [Abstract][Full Text] [Related]
3. A multicenter study of anticoagulation parameters when using heparin and warfarin. Alberts MJ; Massey EW; Dawson D Arch Neurol; 1987 Dec; 44(12):1229-31. PubMed ID: 3675256 [TBL] [Abstract][Full Text] [Related]
4. How Twin Cities neurologists treat ischemic stroke. Policies and trends. Anderson DC Arch Neurol; 1993 Oct; 50(10):1098-103. PubMed ID: 8215971 [TBL] [Abstract][Full Text] [Related]
5. The use of a bolus of intravenous heparin while initiating heparin therapy in anticoagulation following transient ischemic attack or stroke does not lead to increased morbidity or mortality. Toth C Blood Coagul Fibrinolysis; 2003 Jul; 14(5):463-8. PubMed ID: 12851532 [TBL] [Abstract][Full Text] [Related]
6. US national survey of physician practices for the secondary and tertiary prevention of ischemic stroke. Design, service availability, and common practices. Goldstein LB; Bonito AJ; Matchar DB; Duncan PW; DeFriese GH; Oddone EZ; Paul JE; Akin DR; Samsa GP Stroke; 1995 Sep; 26(9):1607-15. PubMed ID: 7660407 [TBL] [Abstract][Full Text] [Related]
7. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy. Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335 [TBL] [Abstract][Full Text] [Related]
8. Validation of a weight-based nomogram for the use of intravenous heparin in transient ischemic attack or stroke. Toth C; Voll C Stroke; 2002 Mar; 33(3):670-4. PubMed ID: 11872885 [TBL] [Abstract][Full Text] [Related]
9. A randomized trial of aspirin or heparin in hospitalized patients with recent transient ischemic attacks. A pilot study. Biller J; Bruno A; Adams HP; Godersky JC; Loftus CM; Mitchell VL; Banwart KJ; Jones MP Stroke; 1989 Apr; 20(4):441-7. PubMed ID: 2648650 [TBL] [Abstract][Full Text] [Related]
10. Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation. Kutner M; Nixon G; Silverstone F Arch Intern Med; 1991 Oct; 151(10):1950-3. PubMed ID: 1929682 [TBL] [Abstract][Full Text] [Related]
11. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework. Lancet; 1998 Jan; 351(9098):233-41. PubMed ID: 9457092 [TBL] [Abstract][Full Text] [Related]
12. Transient ischemic attacks in a 22-year-old. Rogers RK; Sakhuja R; Margey R; Stone JH; Rosenfield K; Jaff MR Am J Med; 2012 Feb; 125(2):148-54. PubMed ID: 22269617 [No Abstract] [Full Text] [Related]
13. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet; 1997 May; 349(9065):1569-81. PubMed ID: 9174558 [TBL] [Abstract][Full Text] [Related]
14. Anticoagulation therapy in Chinese patients with non-valvular atrial fibrillation: a prospective, multi-center, randomized, controlled study. Chen KP; Huang CX; Huang DJ; Cao KJ; Ma CS; Wang FZ; Zhang S Chin Med J (Engl); 2012 Dec; 125(24):4355-60. PubMed ID: 23253701 [TBL] [Abstract][Full Text] [Related]
15. Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention. A population-based study. Petty GW; Brown RD; Whisnant JP; Sicks JD; O'Fallon WM; Wiebers DO Ann Intern Med; 1999 Jan; 130(1):14-22. PubMed ID: 9890845 [TBL] [Abstract][Full Text] [Related]
16. [Anticoagulation and antiaggregation in neurological patients]. Arnold M; Nedeltchev K; Mattle HP Ther Umsch; 2003 Jan; 60(1):33-5. PubMed ID: 12638476 [TBL] [Abstract][Full Text] [Related]
17. Comparison of 2 weight-based heparin dosing nomograms in neurology and vascular surgical patients. Marotti SB; Barras M; Kirkpatrick C Ther Drug Monit; 2015 Feb; 37(1):33-9. PubMed ID: 24831654 [TBL] [Abstract][Full Text] [Related]
18. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Singer DE; Albers GW; Dalen JE; Fang MC; Go AS; Halperin JL; Lip GYH; Manning WJ Chest; 2008 Jun; 133(6 Suppl):546S-592S. PubMed ID: 18574273 [TBL] [Abstract][Full Text] [Related]